Evans D G, Satterwhite T K, Evans D J, DuPont H L
Infect Immun. 1978 Mar;19(3):883-8. doi: 10.1128/iai.19.3.883-888.1978.
Double-blind studies were performed to compare the virulence of enterotoxigenic Escherichia coli with and without the fimbriate colonization factor antigen (CFA), using young healthy adults (mean age, 23 years) as volunteers. In the first study one group of volunteers ingested 1 X 10(6) E. coli H-10407, the CFA-positive strain, and another group ingested 1 X 10(6) E. coli H-10407-P, the CFA-negative spontaneous derivative of strain H-10407. The second study was similar except that the test strains were administered at a dose of 1 X 10(8) viable cells. Three parameters of infection were monitored: (i) diarrhea and associated symptoms; (ii) excretion pattern of test strains; and (iii) humoral antibody response to CFA, somatic antigen, and heat-labile enterotoxin. Significant signs of illness occurred only in six of seven volunteers who ingested E. coli H-10407 at a dose of 1 X 10(8). At both doses, E. coli H-10407-P appeared in the stool on day 1 postchallenge and disappeared by day 4. In contrast, strain H-10407 was persistently excreted from the first to the last day of the study. Also, only those volunteers in the H-10407 challenge groups (12 of 13 analyzed) responded with a fourfold antibody titer rise to CFA, somatic antigen, and/or heat-labile enterotoxin. No reversion of H-10407-P to H-10407 was detected.
进行了双盲研究,以比较有和没有菌毛定居因子抗原(CFA)的产肠毒素大肠杆菌的毒力,使用年轻健康成年人(平均年龄23岁)作为志愿者。在第一项研究中,一组志愿者摄入1×10⁶大肠杆菌H - 10407(CFA阳性菌株),另一组摄入1×10⁶大肠杆菌H - 10407 - P(H - 10407菌株的CFA阴性自发衍生物)。第二项研究与之相似,只是测试菌株的给药剂量为1×10⁸个活细胞。监测了感染的三个参数:(i)腹泻及相关症状;(ii)测试菌株的排泄模式;(iii)对CFA、菌体抗原和不耐热肠毒素的体液抗体反应。只有7名摄入剂量为1×10⁸的大肠杆菌H - 10407的志愿者中的6人出现了明显的疾病症状。在两个剂量下,大肠杆菌H - 10407 - P在攻击后第1天出现在粪便中,并在第4天消失。相比之下,H - 10407菌株在研究的第一天到最后一天持续排泄。此外,只有H - 10407攻击组中的那些志愿者(13人中的12人接受分析)对CFA、菌体抗原和/或不耐热肠毒素的抗体滴度有四倍升高反应。未检测到H - 10407 - P回复为H - 10407。